Fluorescent Chitosan Polymers for Stable Vascular Imaging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing fluorescent markers for visualizing glycosamine-containing structures, such as blood vessels, are chemically unstable, toxic, and inefficient, limiting their effectiveness in vascular imaging.

Innovation Solution

Development of fluorescent water-soluble polycationic chitosan polymers conjugated with polymethine dyes, which are chemically stable, non-toxic, and offer improved imaging efficiency by targeting glycosamine-containing structures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Illumination intensity

If MHI148 dye is used for vascular staining, then fluorescence imaging can be achieved, but chemical stability deteriorates due to sensitivity to chemical and photoinduced decomposition

Engineering Contradiction:
Improvefluorescence imaging capabilityVSAvoidchemical stability
Core Design Contradiction:
Illumination intensityVSStability of the object's composition

Solution Approach 1:

The patent uses chitosan polymer as an intermediary carrier to conjugate with MHI148 dye. The chitosan backbone provides structural stability and protects the fluorescent dye from chemical and photoinduced decomposition, while still allowing the dye to maintain its fluorescence imaging capability. This mediator approach resolves the contradiction between achieving fluorescence and maintaining chemical stability.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention creates a composite material by conjugating MHI148 dye with chitosan polymer to form a stable fluorescent conjugate. The composite structure combines the fluorescent properties of MHI148 with the chemical stability and water solubility of chitosan, simultaneously achieving both fluorescence imaging capability and enhanced chemical stability.

Inventive Principle:
Principle #40Composite materials

2Illumination intensity

If PEI is used as a carrier for fluorescent dye, then vascular visualisation can be achieved, but toxicity worsens due to cellular toxicity

Engineering Contradiction:
Improvevascular visualisation capabilityVSAvoidcellular toxicity
Core Design Contradiction:
Illumination intensityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical parameter of the polymer carrier from polyethyleneimine (PEI) to chitosan. This parameter change maintains the polycationic nature and glycosamine-containing structure necessary for vascular binding, while fundamentally altering the toxicity profile from highly toxic PEI to biocompatible chitosan, thus resolving the toxicity issue while preserving imaging functionality.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces the toxic but effective PEI carrier with chitosan, which is naturally biodegradable and biocompatible. This substitution uses a material that is inherently safer for biological applications, allowing the fluorescent marker to perform its visualisation function without causing cellular toxicity, effectively replacing a harmful substance with a benign alternative.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Measurement precision

If blue and green region dyes are used for fluorescence imaging, then specific staining can be achieved, but tissue penetration depth worsens due to poor penetration and autofluorescence disturbance

Engineering Contradiction:
Improvestaining specificityVSAvoidtissue penetration depth
Core Design Contradiction:
Measurement precisionVSLength of stationary object

Solution Approach 1:

The patent modifies the optical parameter of the fluorescent marker by selecting MHI148 dye, which emits in the red/near-infrared region rather than blue/green. This parameter change in emission wavelength simultaneously improves tissue penetration depth and reduces autofluorescence interference, while the glycosamine-containing chitosan structure maintains specific binding to vascular structures.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new fluorescent markers provide reproducible, efficient, and non-toxic imaging of glycosamine-containing structures, offering enhanced spatial resolution and reduced toxicity compared to previous markers.

Implementation Method 1

Fluorescent water-soluble polycationic chitosan polymers and use thereof as imaging agents for imaging glycosamine-containing structures

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 2

MHI148-PEI uses branched PEI of molecular weight 70 kDa, conjugated to a cationic cyanine 7 dye and binds to glycosamine containing biological structures basing on an electrostatic interaction

Methodology Applied
Scientific EffectElectrostatic interaction: Electrostatics

Data Source

PatentEP4360659B1Fluorescent water-soluble polycationic chitosan polymers as markers for biological 3D imaging
Publication Date: 2025.04.30 CYANAGEN
  • EP4360659B1 patent drawingFigure 1(a)~1(f)
  • EP4360659B1 patent drawingFigure 2(a)~2(b)
  • EP4360659B1 patent drawingFigure 2(c)

AI summary

A fluorescent water-soluble polycationic chitosan polymer having a general formula (I) and salts thereof: wherein a is an integer between 220 and 11,200; R1 and R2 are independently selected from the group consisting of CH3CO and H, provided that at least 25% of the O-positions of the chitosan polymer structure is substituted with CH3CO; R7 is selected from the group consisting of CH3CO, H and Dye, provided that (i) at least one Dye residue is present in the chitosan polymer structure, (ii) and at least 15% of the N-positions of the chitosan polymer structure is substituted with CH3CO; Dye is a polymethine dye, having a general formula (II) : wherein W represents 4-8 carbon atoms forming a benzo-condensed or a naphto-condensed ring; R3 and R4 are independently selected from the group consisting of CH2CH3, (CH2)3SO3-, (CH2)3N+(CH3)3; R5 and R6 are independently selected from the group consisting of H, SO3-; Q is selected from the group consisting of wherein D is selected from the group consisting of